The Michael J. Fox Foundation for Parkinson’s Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study


(July 15, 2014) - Biotie Therapies has signed a $2M research contract with The Michael J. Fox Foundation (MJFF) to investigate SYN120 in Parkinson's disease patients with dementia. This could result in a unique therapeutic profile for SYN120 combining pro-cognitive and antipsychotic activities. Read more…

Click for a printer friendly version

Back to top